The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Jet Lag Medication Market Research Report 2024
Synopsis
Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
Global Jet Lag Medication market is projected to reach US$ 726.1 million in 2029, increasing from US$ 480 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Jet Lag Medication market research.
Key companies engaged in the Jet Lag Medication industry include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Jet Lag Medication were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Jet Lag Medication market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Jet Lag Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Segment by Type
Prescription Drugs
OTC
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Jet Lag Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Jet lag, also called jet lag disorder, is a temporary sleep problem that can affect anyone who quickly travels across multiple time zones. Jet lag can cause daytime fatigue, an unwell feeling, difficulty staying alert and gastrointestinal problems. Jet lag is temporary, but it can significantly reduce vacation or business travel comfort. Jet lag does not usually require treatment. Symptoms often improve within a few days, though they sometimes last longer. However, if you're a frequent traveler continually bothered by jet lag, your doctor may prescribe medications.
Global Jet Lag Medication market is projected to reach US$ 726.1 million in 2029, increasing from US$ 480 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Jet Lag Medication market research.
Key companies engaged in the Jet Lag Medication industry include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan and Clinigen Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Jet Lag Medication were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Jet Lag Medication market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Jet Lag Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Segment by Type
Prescription Drugs
OTC
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Jet Lag Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Jet Lag Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Jet Lag Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Jet Lag Medication Market Perspective (2018-2029)
2.2 Jet Lag Medication Growth Trends by Region
2.2.1 Global Jet Lag Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Jet Lag Medication Historic Market Size by Region (2018-2023)
2.2.3 Jet Lag Medication Forecasted Market Size by Region (2024-2029)
2.3 Jet Lag Medication Market Dynamics
2.3.1 Jet Lag Medication Industry Trends
2.3.2 Jet Lag Medication Market Drivers
2.3.3 Jet Lag Medication Market Challenges
2.3.4 Jet Lag Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Jet Lag Medication Players by Revenue
3.1.1 Global Top Jet Lag Medication Players by Revenue (2018-2023)
3.1.2 Global Jet Lag Medication Revenue Market Share by Players (2018-2023)
3.2 Global Jet Lag Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Jet Lag Medication Revenue
3.4 Global Jet Lag Medication Market Concentration Ratio
3.4.1 Global Jet Lag Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Jet Lag Medication Revenue in 2022
3.5 Jet Lag Medication Key Players Head office and Area Served
3.6 Key Players Jet Lag Medication Product Solution and Service
3.7 Date of Enter into Jet Lag Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Jet Lag Medication Breakdown Data by Type
4.1 Global Jet Lag Medication Historic Market Size by Type (2018-2023)
4.2 Global Jet Lag Medication Forecasted Market Size by Type (2024-2029)
5 Jet Lag Medication Breakdown Data by Application
5.1 Global Jet Lag Medication Historic Market Size by Application (2018-2023)
5.2 Global Jet Lag Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Jet Lag Medication Market Size (2018-2029)
6.2 North America Jet Lag Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Jet Lag Medication Market Size by Country (2018-2023)
6.4 North America Jet Lag Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Jet Lag Medication Market Size (2018-2029)
7.2 Europe Jet Lag Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Jet Lag Medication Market Size by Country (2018-2023)
7.4 Europe Jet Lag Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Jet Lag Medication Market Size (2018-2029)
8.2 Asia-Pacific Jet Lag Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Jet Lag Medication Market Size by Region (2018-2023)
8.4 Asia-Pacific Jet Lag Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Jet Lag Medication Market Size (2018-2029)
9.2 Latin America Jet Lag Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Jet Lag Medication Market Size by Country (2018-2023)
9.4 Latin America Jet Lag Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Jet Lag Medication Market Size (2018-2029)
10.2 Middle East & Africa Jet Lag Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Jet Lag Medication Market Size by Country (2018-2023)
10.4 Middle East & Africa Jet Lag Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Jet Lag Medication Introduction
11.1.4 Teva Revenue in Jet Lag Medication Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Jet Lag Medication Introduction
11.2.4 Mylan Revenue in Jet Lag Medication Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Detail
11.3.2 Nature’s Bounty Business Overview
11.3.3 Nature’s Bounty Jet Lag Medication Introduction
11.3.4 Nature’s Bounty Revenue in Jet Lag Medication Business (2018-2023)
11.3.5 Nature’s Bounty Recent Development
11.4 Otsuka Pharma (Pharmavite)
11.4.1 Otsuka Pharma (Pharmavite) Company Detail
11.4.2 Otsuka Pharma (Pharmavite) Business Overview
11.4.3 Otsuka Pharma (Pharmavite) Jet Lag Medication Introduction
11.4.4 Otsuka Pharma (Pharmavite) Revenue in Jet Lag Medication Business (2018-2023)
11.4.5 Otsuka Pharma (Pharmavite) Recent Development
11.5 Boiron
11.5.1 Boiron Company Detail
11.5.2 Boiron Business Overview
11.5.3 Boiron Jet Lag Medication Introduction
11.5.4 Boiron Revenue in Jet Lag Medication Business (2018-2023)
11.5.5 Boiron Recent Development
11.6 Miers Laboratories
11.6.1 Miers Laboratories Company Detail
11.6.2 Miers Laboratories Business Overview
11.6.3 Miers Laboratories Jet Lag Medication Introduction
11.6.4 Miers Laboratories Revenue in Jet Lag Medication Business (2018-2023)
11.6.5 Miers Laboratories Recent Development
11.7 Genexa
11.7.1 Genexa Company Detail
11.7.2 Genexa Business Overview
11.7.3 Genexa Jet Lag Medication Introduction
11.7.4 Genexa Revenue in Jet Lag Medication Business (2018-2023)
11.7.5 Genexa Recent Development
11.8 Homeocan
11.8.1 Homeocan Company Detail
11.8.2 Homeocan Business Overview
11.8.3 Homeocan Jet Lag Medication Introduction
11.8.4 Homeocan Revenue in Jet Lag Medication Business (2018-2023)
11.8.5 Homeocan Recent Development
11.9 Clinigen Group
11.9.1 Clinigen Group Company Detail
11.9.2 Clinigen Group Business Overview
11.9.3 Clinigen Group Jet Lag Medication Introduction
11.9.4 Clinigen Group Revenue in Jet Lag Medication Business (2018-2023)
11.9.5 Clinigen Group Recent Development
11.10 Vanda Pharma
11.10.1 Vanda Pharma Company Detail
11.10.2 Vanda Pharma Business Overview
11.10.3 Vanda Pharma Jet Lag Medication Introduction
11.10.4 Vanda Pharma Revenue in Jet Lag Medication Business (2018-2023)
11.10.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
